The Precision Peptide Company Applauds FDA Advisory Committee Vote on Expanded Pathway for BPC-157 and KPV On July 23, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 8-6 (one abstention) to recommend BPC-157 for inclusion on the Section 503A Bulks List
BPC 157 is a well-known peptide thats beloved for its incredible healing abilities, and its becoming more and more sought-after by those seeking rapid recovery aids, or who are simply interested in boosting the speed of recovery from injuries and joint damage to enjoy improved overall wellness.1 2 3 Its derived synthetically from a protein found in the stomach, and this body-protective compound has been shown in research to have substantial effects in accelerating wound healing, specifically in tissues like tendons, muscles, and nerves.4 5 6 7 #1
1,2 10 Units divided in 2 sites 5 Units in 1 site 20 Units divided in 4 sites 40 Units divided in 8 sites 30 Units divided in 6 sites 20 Units divided in 4 sites 30 Units divided in 6 sites TOTAL DOSE : 155 Units divided between 31 sites * PREEMPT = P hase 3 RE search E valuating M igraine P rophylaxis T herapy
Leading to decreased inflammation and tissue damage
Connor Yost is an Internal Medicine resident at Creighton University School of Medicine in Arizona and an emerging leader in clinical innovation